319 reports of this reaction
2.6% of all ENFORTUMAB VEDOTIN reports
#8 most reported adverse reaction
DEATH is the #8 most commonly reported adverse reaction for ENFORTUMAB VEDOTIN, manufactured by SEAGEN INC.. There are 319 FDA adverse event reports linking ENFORTUMAB VEDOTIN to DEATH. This represents approximately 2.6% of all 12,251 adverse event reports for this drug.
Patients taking ENFORTUMAB VEDOTIN who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a less commonly reported adverse event for ENFORTUMAB VEDOTIN, but still significant enough to appear in the safety profile.
In addition to death, the following adverse reactions have been reported for ENFORTUMAB VEDOTIN:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 319 FDA reports for ENFORTUMAB VEDOTIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 2.6% of all adverse event reports for ENFORTUMAB VEDOTIN, making it a notable side effect.
If you experience death while taking ENFORTUMAB VEDOTIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.